Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                About MCMi

About MCMi

                        MCMi News and Events
          MCMi Newsletters
          Publications and Reports
          Medical Countermeasure Resources
          What are Medical Countermeasures?
          MCMi History Home
          Emergency Preparedness and Response
          Counterterrorism and Emerging Threats
          Medical Countermeasures Initiative (MCMi)
          About MCMi
          MCMi HistoryAbout MCMi MCMi History
  
  					MCMi is an FDA-wide initiative to coordinate medical countermeasure development, preparedness and response
	
    Subscribe to Email Updates
    Share
    Post
    Linkedin

    Email
    PrintImage
              Graphic representing history of the FDA Medical Countermeasures Initiative (MCMi)On this page: About MCMi | MCMi history | Contact us

About MCMi

The Medical Countermeasures Initiative (MCMi) is an FDA-wide initiative to coordinate medical countermeasure development, preparedness and response, led by the Office of Counterterrorism and Emerging Threats (OCET) in the Office of the Chief Scientist (OCS).

FDA plays a critical role in protecting the United States from chemical, biological, radiological, nuclear, and emerging infectious disease threats. FDA ensures that medical countermeasures (MCMs)—including drugs, vaccines and diagnostic tests—to counter these threats are safe, effective, and secure.

Together with U.S. government partners through the Department of Health and Human Services Public Health Emergency Medical Countermeasures Enterprise (PHEMCE), FDA helps define and prioritize requirements for MCMs in public health emergencies. This includes coordinating research, setting deployment and use strategies, and facilitating access to MCMs.

MCMi history

FDA launched  MCMi in August 2010 in response to a comprehensive, year‐long review of the PHEMCE. The review was ordered by the Department of Health and Human Services (HHS) Secretary to assess our nation’s readiness for future public health emergencies, and improve our nation’s capacity to respond faster and more effectively to chemical, biological, radiological, nuclear (CBRN), and emerging infectious disease threats, such as pandemic influenza.

MCMi builds on programs already under way at FDA medical product centers, and devotes additional resources to foster the development and availability of medical products that will be needed to counter public health emergencies.

Contact MCMi

Email: AskMCMi@fda.hhs.gov

Twitter: @FDA_MCMi

Office of Counterterrorism and Emerging Threats (OCET)
Michael Mair, MPH
Assistant Commissioner for Counterterrorism Policy, and Director, Office of Counterterrorism and Emerging Threats

                                                                                  Content current as of:
      02/22/2023About MCMi

          
                        MCMi News and Events
          MCMi Newsletters
          Publications and Reports
          Medical Countermeasure Resources
          What are Medical Countermeasures?
          MCMi History
 Subscribe
                        Sign up to receive email alerts on emergency preparedness and response topics from FDA, including medical countermeasures and emerging infectious diseases.
    Enter your email address to subscribe:
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop